Urology Doctors in Salem, MA Accepting Medicare

7 Urology doctors found. Showing 1 - 7

Dr. David H Kauder, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 400 Highland Ave, Suite 6, Salem, MA 01970 Phone: 978-741-4133    Fax: 978-741-7742

Dr. Mark Laspina, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 400 Highland Ave, Suite 6, Salem, MA 01970 Phone: 978-741-4133    Fax: 978-741-7742

Mr. Noel P Defelippo, MD Urology Medicare: Medicare Enrolled Practice Location: 400 Highland Ave, Suite 6, Salem, MA 01970 Phone: 978-741-4133    Fax: 978-741-7742

Dr. Alejandra Balen, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 400 Highland Ave, Salem, MA 01970 Phone: 978-741-4133    Fax: 978-741-7742

Dr. Anthony M Filoso, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 400 Highland Ave, Suite 6, Salem, MA 01970 Phone: 978-741-4133    Fax: 978-741-7742

Mr. Michael G Callum, MD Urology Medicare: Medicare Enrolled Practice Location: 400 Highland Ave, Suite 6, Salem, MA 01970 Phone: 978-741-4133    Fax: 978-741-7742

Mr. Thomas E Kingston, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 400 Highland Ave, Suite 6, Salem, MA 01970 Phone: 978-741-4133    Fax: 978-741-7742

News Archive

Breast-conserving treatment may be a viable alternative to mastectomy, study suggests

Approximately 10% of breast cancer patients treated with lumpectomy (breast-conserving surgery [BCS]) and whole-breast radiation (WBI) will have a subsequent in-breast local recurrence of cancer (IBTR) when followed long term.

Mologic begins clinical trial to evaluate urine-based diagnostic for cystic fibrosis

Mologic Ltd, a developer of powerful, personalized diagnostics to improve the lives of patients, today announced that it has commenced a clinical trial to evaluate the Company's urine-based diagnostic, HeadsUp, in monitoring pulmonary exacerbation in cystic fibrosis patients.

Anti-Infective Drugs Advisory Committee to review aztreonam for inhalation solution

Gilead Sciences, Inc. today announced that aztreonam for inhalation solution, an investigational product for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF), is scheduled to be reviewed by the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) on December 10, 2009.

Life Technologies launches Qubit 2.0 Fluorometer for molecular biology research

Life Technologies Corporation, a provider of innovative life science solutions, today announced the launch of its next-generation Qubit® 2.0 Fluorometer specifically for molecular biology researchers who work with precious samples and perform applications that require a large financial or time investment. The new system quantitates DNA, RNA and protein with accuracy, sensitivity, speed and ease-of-use.

Read more Medical News

› Verified 3 days ago